L&C Bio Turns Profitable on Rituo Success as Conversion-Rights Risk Draws Attention

L&C Bio has returned to profit, supported by the strong performance of Rituo, according to an analysis cited by Korea Economic Daily. The central point of the report is that robust Rituo sales helped drive an improvement in earnings. However, the analysis also flagged the risk of conversion-rights exercise as a factor investors should monitor. If such rights are exercised, they could weigh on existing shareholder value and market supply, so the profit turnaround should be assessed together with the durability of earnings recovery and possible share overhang. Source: hankyung.com